[go: up one dir, main page]

PT95061A - Processo para a preparacao de uma composicao para o tratamento de reaccoes de hipersensibilidade, inflamacao ou hiperproliferacao cutanea, ocular ou das mucosas, que compreende dimetil ester do acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridinadicarboxilico (nifedipina) - Google Patents

Processo para a preparacao de uma composicao para o tratamento de reaccoes de hipersensibilidade, inflamacao ou hiperproliferacao cutanea, ocular ou das mucosas, que compreende dimetil ester do acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridinadicarboxilico (nifedipina) Download PDF

Info

Publication number
PT95061A
PT95061A PT95061A PT9506190A PT95061A PT 95061 A PT95061 A PT 95061A PT 95061 A PT95061 A PT 95061A PT 9506190 A PT9506190 A PT 9506190A PT 95061 A PT95061 A PT 95061A
Authority
PT
Portugal
Prior art keywords
nifedipine
hyperproliferaca
inflammation
preparation
dimethyl
Prior art date
Application number
PT95061A
Other languages
English (en)
Portuguese (pt)
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of PT95061A publication Critical patent/PT95061A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT95061A 1989-08-21 1990-08-21 Processo para a preparacao de uma composicao para o tratamento de reaccoes de hipersensibilidade, inflamacao ou hiperproliferacao cutanea, ocular ou das mucosas, que compreende dimetil ester do acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridinadicarboxilico (nifedipina) PT95061A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39684689A 1989-08-21 1989-08-21

Publications (1)

Publication Number Publication Date
PT95061A true PT95061A (pt) 1991-05-22

Family

ID=23568865

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95061A PT95061A (pt) 1989-08-21 1990-08-21 Processo para a preparacao de uma composicao para o tratamento de reaccoes de hipersensibilidade, inflamacao ou hiperproliferacao cutanea, ocular ou das mucosas, que compreende dimetil ester do acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridinadicarboxilico (nifedipina)

Country Status (5)

Country Link
AU (1) AU6291990A (fr)
IE (1) IE903013A1 (fr)
PT (1) PT95061A (fr)
WO (1) WO1991002497A1 (fr)
ZA (1) ZA906583B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
AU2385795A (en) * 1994-04-12 1995-10-30 Alza Corporation Screening methods for integumental inflammation modulating agents
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
FR2758263B1 (fr) * 1997-01-16 1999-12-17 Oreal Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
AU727080B2 (en) 1997-06-30 2000-11-30 Allergan, Inc. Calcium blockers to treat proliferative vitreoretinopathy
US6031005A (en) * 1998-08-03 2000-02-29 Easterling; W. Jerry Composition and method for treating Peyronie's disease and related connective tissue disorders
FR2793681B1 (fr) 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
EP1789031A2 (fr) * 2004-08-18 2007-05-30 Ace ApS Compositions cosmetiques et pharmaceutiques contenant des inhibiteurs de l'eca et/ou des antagonistes des recepteurs de l'angiotensine ii
ITRM20060440A1 (it) * 2006-08-10 2008-02-11 Carmine Antropoli Uso della nifedipina per il trattamento antirughe
CA2968861C (fr) * 2017-05-30 2022-10-11 University Of Saskatchewan Formulations de nifedipine topiques et utilisations associees

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
DE3601196A1 (de) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-dihydropyridine

Also Published As

Publication number Publication date
AU6291990A (en) 1991-04-03
ZA906583B (en) 1991-09-25
IE903013A1 (en) 1991-02-27
WO1991002497A1 (fr) 1991-03-07

Similar Documents

Publication Publication Date Title
EP0489108B1 (fr) Utilisation des derivatives de spiperone pour immunosuppresion
PT95061A (pt) Processo para a preparacao de uma composicao para o tratamento de reaccoes de hipersensibilidade, inflamacao ou hiperproliferacao cutanea, ocular ou das mucosas, que compreende dimetil ester do acido 1,4-dihidro-2,6-dimetil-4-(2-nitrofenil)-3,5-piridinadicarboxilico (nifedipina)
JP2683390B2 (ja) 局所適用のための医薬又は化粧品組成物
JPS6118718A (ja) 抗炎症製薬組成物
BR0307550B1 (pt) composição farmacêutica em gel tópica, de adapaleno 0,3%
US5219880A (en) Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
PT1560589E (pt) Novos complexos de ésteres de ácidos gordos de polihidroxialcanos e niacinamida
EP3082752A1 (fr) Utilisation d'alkylamidothiazoles dans des préparations cosmétiques ou dermatologiques pour assurer la prophylaxie et le traitement des peaux sensibles
JP2655190B2 (ja) コルチコステロイド含有軟膏剤
BG62032B1 (bg) Антивирусна активна фармацевтична емулсия от масло във вода,съдържаща ацикловир или негова сол, или естер
US4034114A (en) Treatment of skin keratoses with retinal
WO2002000214A1 (fr) Derives de flavone/flavanone pour le traitement systematique et la prophylaxie de dermatoses associees aux uv
PT94848A (pt) Processo de producao de preparacoes farmaceuticas topicas a base de antocianidinas
ES2223676T3 (es) Agente terapeutico para el tratamiento de dermatitis.
ITMI970751A1 (it) Nimesulide sale di colina, metodo di preparazione e composizioni farmaceutiche che lo contengono
AU656121C (en) Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
EP0502205A1 (fr) Derive de chalone et cosmetique filtrant les ultraviolets
EP1507524B1 (fr) Utilisation topicale de diuretiques pour traiter les oedemes
DE3741414A1 (de) Verwendung von calciumantagonisten bei der behandlung von entzuendungen und oedemen
EP0480996A1 (fr) Alcaloides de benzophenanthridine pour le traitement local de l'acne
US20100010052A1 (en) Topical composition comprising a dihydropyridine calcium antagonist
US20080004235A1 (en) Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine
JPH01301612A (ja) 育毛剤
RU2426540C1 (ru) Противовоспалительное и противоаллергическое лекарственное средство и фармацевтическая композиция на его основе
JPH072676A (ja) 医薬品および／または化粧品調製剤

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910110

FC3A Refusal

Effective date: 19960905